Michael Belshan

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

Christopher J. Destache, Todd Belgum, Michael Goede et al. · Journal of Antimicrobial Chemotherapy · 2010 · 81 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission

Martina Kovářová, Abhijit A. Date, Julie M. Long et al. · PLoS Pathogens · 2015 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment

Annemarie Shibata, Emily Mcmullen, Alex Pham et al. · AIDS Research and Human Retroviruses · 2013 · 77 citations

Pharmacy, Infectious Diseases, Pharmaceutics +17

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma

For Yue Tso, Salum J. Lidenge, Lisa K. Poppe et al. · PLoS ONE · 2021 · 73 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Genetic and Biological Variation in Equine Infectious Anemia Virus Rev Correlates with Variable Stages of Clinical Disease in an Experimentally Infected Pony

Michael Belshan, Prasith Baccam, J. Lindsay Oaks et al. · Virology · 2001 · 59 citations

Veterinary Medicine, Infectious Diseases, Veterinary Microbiology +15